Mouse models for studying genetic influences on factors determining smoking cessation success in humans.
Humans differ in their ability to quit using addictive substances, including nicotine, the major psychoactive ingredient in tobacco. For tobacco smoking, a substantial body of evidence, largely derived from twin studies, indicates that approximately half of these individual differences in ability to quit are heritable genetic influences that likely overlap with those for other addictive substances. Both twin and molecular genetic studies support overlapping influences on nicotine addiction vulnerability and smoking cessation success, although there is little formal analysis of the twin data that support this important point. None of the current datasets provides clarity concerning which heritable factors might provide robust dimensions around which individuals differ in ability to quit smoking. One approach to this problem is to test mice with genetic variations in genes that contain human variants that alter quit success. This review considers which features of quit success should be included in a comprehensive approach to elucidate the genetics of quit success, and how those features may be modeled in mice.
Molecular Neurobiology Branch, NIH-IRP, NIDA, Baltimore, Maryland 21224, USA.
F Scott
FS
Hall
Athina
A
Markou
Edward D
ED
Levin
George R
GR
Uhl
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D012307:Risk Factors; D016540:Smoking Cessation; D013375:Substance Withdrawal Syndrome / Q000453:epidemiology / Q000235:genetics*; D014029:Tobacco Use Disorder / Q000453:epidemiology / Q000235:genetics / Q000628:therapy